Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- Baxter Healthcare Ltd, Biocon, Dr Reddy's Laboratories (UK) Ltd SME, Sun Pharma UK Ltd, Thornton & Ross SME, Zentiva Pharma UK Ltd
- Value
- £9,867,000
- Procedure
- Open procedure (above threshold)
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- North West
- Official notice
- View on Contracts Finder
- Timeline
-
- Contract date14 Jan 2025
- Published21 Jan 2025Published 7 days after the contract date
Description
Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
About the suppliers
Baxter Healthcare Ltd: every public contract they have won, plus their Companies House record (company 00461365).
Biocon: every public contract they have won, plus their Companies House record (company 11716196).
Dr Reddy's Laboratories (UK) Ltd: every public contract they have won, plus their Companies House record (company 01729064).
Sun Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02992795).
Thornton & Ross: every public contract they have won, plus their Companies House record (company 00185947).
Zentiva Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02158996).